Circulatory soluble LOX-1 is a novel predictor for coronary artery disease patients

被引:3
|
作者
Sheikh, Md Sayed Ali [1 ]
机构
[1] Jouf Univ, Dept Internal Med, Coll Med, Sakaka, Aljouf, Saudi Arabia
关键词
coronary artery disease; soluble LOX-1; biomarker; aging; EXPRESSION;
D O I
10.5830/CVJA-2022-038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study investigated the biomarker effect of soluble lectin-like oxidised low-density lipoprotein (sLOX-1) levels for the evaluation of stable and unstable coronary heart disease, correlating it with aging. Methods: This case-control study was conducted at the Cardiology Department of Xiangya Hospital between June 2015 and September 2018. Stable coronary artery disease (CAD) patients were confirmed by an invasive coronary angiogram, and American College of Cardiology as well as European Cardiology Society clinical protocols were used for the diagnosis of unstable CAD subjects. Plasma sLOX-1 levels were determined from 226 stable CAD patients, 138 unstable CAD subjects and 75 healthy participants by enzyme-linked immunosorbent assay. Results: Plasma sLOX-1 expressions were significantly elevated in stable CAD patients (4.5-fold) and unstable CAD patients (5.8-fold) above that of volunteer healthy participants. Moreover, between the stable and unstable patient groups, sLOX-1 concentrations were also statistically significantly different (p < 0.001). Levels of plasma sLOX-1 in the healthy female (30-60 years), and stable and unstable CAD female subjects (61-84 years) were markedly elevated compared with healthy male (30-60 years), as well as stable and unstable CAD male patients (61-84 years) (p < 0.001). Besides, in the female unstable CAD (61-84 years) subjects, circulatory sLOX-1 expressions were much higher than in the younger female unstable CAD (30-60 years) patients (p < 0.001). The stable CAD patients were clearly differentiated from healthy subjects with a high sensitivity of the area under the curve (AUC = 0.895). Unstable CAD patients and healthy subjects were also markedly different with a high sensitivity, as shown by AUC (0.902). Stable and unstable CAD subjects were differentiated with an AUC of 0.867. Conclusion: Elevated plasma sLOX-1 levels could be regarded as a novel biomarker for detecting CAD patients and there was a significant association with gender and aging.
引用
收藏
页码:104 / 108
页数:5
相关论文
共 50 条
  • [1] Soluble LOX-1: A Novel Biomarker in Patients With Coronary Artery Disease, Stroke, and Acute Aortic Dissection?
    Hofmann, Anja
    Brunssen, Coy
    Wolk, Steffen
    Reeps, Christian
    Morawietz, Henning
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (01):
  • [2] The LOX-1 scavenger receptor and its implication in coronary artery disease
    Pant, Sadip
    Deshmukh, Abhishek
    Mehta, J. L.
    CLINICAL LIPIDOLOGY, 2012, 7 (03) : 271 - 273
  • [3] LOX-1, a new marker of risk and prognosis in coronary artery disease?
    Lubrano, Valter
    Balzan, Silvana
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2013, 383 (1-2) : 223 - 230
  • [4] LOX-1, a new marker of risk and prognosis in coronary artery disease?
    Valter Lubrano
    Silvana Balzan
    Molecular and Cellular Biochemistry, 2013, 383 : 223 - 230
  • [5] LOX-1 is a novel marker for peripheral artery disease in patients with type 2 diabetes
    Fukui, Michiaki
    Tanaka, Muhei
    Senmaru, Takafumi
    Nakanishi, Mamoru
    Mukai, Jun
    Ohki, Makoto
    Asano, Mai
    Yamazaki, Masahiro
    Hasegawa, Goji
    Nakamura, Naoto
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (07): : 935 - 938
  • [6] The LOX-1 3'UTR188CT polymorphism and coronary artery disease in Turkish patients
    Kurnaz, Ozlem
    Akadam-Teker, A. Basak
    Yilmaz-Aydogan, Hulya
    Tekeli, Atike
    Isbir, Turgay
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (04) : 4351 - 4358
  • [7] The LOX-1 3′UTR188CT polymorphism and coronary artery disease in Turkish patients
    Özlem Kurnaz
    A. Başak Akadam-Teker
    Hülya Yilmaz-Aydoğan
    Atike Tekeli
    Turgay İsbir
    Molecular Biology Reports, 2012, 39 : 4351 - 4358
  • [8] IS LOX-1 K167N POLYMORPHISM PROTECTIVE FOR CORONARY ARTERY DISEASE?
    Kurnaz, Ozlem
    Yilmaz-Aydogan, Hulya
    Isbir, Selim
    Tekeli, Atike
    Isbir, Turgay
    IUBMB LIFE, 2009, 61 (03) : 321 - 321
  • [9] Is LOX-1 K167N Polymorphism Protective for Coronary Artery Disease?
    Kurnaz, Oezlem
    Aydogan, Huelya Yilmaz
    Isbir, C. Selim
    Tekeli, Atike
    Isbir, Turgay
    IN VIVO, 2009, 23 (06): : 969 - 973
  • [10] THE EFFECTS OF LOX-1 3'UTR188 CT POLYMORPHISM ON CORONARY ARTERY DISEASE IN TURKISH PATIENTS
    Kurnaz, Ozlem
    Yilmaz-Aydogan, Hulya
    Isbir, Selim
    Tekeli, Atike
    Isbir, Turgay
    IUBMB LIFE, 2009, 61 (03) : 321 - 322